menu
    • menu
    [{"orgOrder":0,"company":"Koffler Vision Group","sponsor":"Akorn Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"CANADA","productType":"Carbohydrate","year":"2016","type":"Inapplicable","leadProduct":"Sodium Carboxymethylcellulose","moa":"Human corneal endothelial cells","graph1":"Ophthalmology","graph2":"Phase IV","graph3":"Koffler Vision Group","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Solution","sponsorNew":"Koffler Vision Group \/ Akorn Inc","highestDevelopmentStatusID":"11","companyTruncated":"Koffler Vision Group \/ Akorn Inc"},{"orgOrder":0,"company":"Akorn Pharmaceuticals","sponsor":"Prestige Consumer Healthcare","pharmaFlowCategory":"D","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Carbohydrate","year":"2021","type":"Divestment","leadProduct":"Sodium Carboxymethylcellulose","moa":"Human corneal endothelial cells","graph1":"Ophthalmology","graph2":"Approved FDF","graph3":"Akorn Pharmaceuticals","amount2":0.23000000000000001,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Ophthalmology","amount2New":0.23000000000000001,"dosageForm":"Solution","sponsorNew":"Akorn Pharmaceuticals \/ Prestige Consumer Healthcare","highestDevelopmentStatusID":"15","companyTruncated":"Akorn Pharmaceuticals \/ Prestige Consumer Healthcare"},{"orgOrder":0,"company":"Allergan","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"","productType":"Carbohydrate","year":"2014","type":"Inapplicable","leadProduct":"Sodium Carboxymethylcellulose","moa":"Human corneal endothelial cells","graph1":"Ophthalmology","graph2":"Phase IV","graph3":"Allergan","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Gel","sponsorNew":"Allergan \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Allergan \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for CMC 7M

    Menu

    CMC 7M

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Akorn Pharmaceuticals

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed

                            Akorn Pharmaceuticals

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sodium Carboxymethylcellulose

                            Therapeutic Area : Ophthalmology

                            Study Phase : Approved FDF

                            Sponsor : Prestige Consumer Healthcare

                            Deal Size : $230.0 million

                            Deal Type : Divestment

                            DEALS_DEV arrow-down

                            Akorn Announces Agreement to Sell its Consumer Health Business to Prestige Consumer Healthcare

                            Details : The Consumer Health business primarily consists of the following over-the-counter brands: TheraTears , Diabetic Tussin , MagOx , Multi-betic , and Zostrix.

                            Product Name : TheraTears

                            Product Type : Carbohydrate

                            Upfront Cash : $230.0 million

                            May 27, 2021

                            Lead Product(s) : Sodium Carboxymethylcellulose

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Approved FDF

                            Sponsor : Prestige Consumer Healthcare

                            Deal Size : $230.0 million

                            Deal Type : Divestment

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Koffler Vision Group

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            Koffler Vision Group

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sodium Carboxymethylcellulose

                            Therapeutic Area : Ophthalmology

                            Study Phase : Phase IV

                            Sponsor : Akorn Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops

                            Details : TheraTears (Sodium Carboxymethylcellulose) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dry Eye Syndromes.

                            Product Name : TheraTears

                            Product Type : Carbohydrate

                            Upfront Cash : Inapplicable

                            May 02, 2016

                            Lead Product(s) : Sodium Carboxymethylcellulose

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Phase IV

                            Sponsor : Akorn Pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Allergan

                            Country arrow
                            OTS 2025
                            Not Confirmed

                            Allergan

                            Country arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Sodium Carboxymethylcellulose

                            Therapeutic Area : Ophthalmology

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms

                            Details : Sodium Carboxymethylcellulose is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dry Eye Syndromes.

                            Product Name : Undisclosed

                            Product Type : Carbohydrate

                            Upfront Cash : Inapplicable

                            January 07, 2014

                            Lead Product(s) : Sodium Carboxymethylcellulose

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth